CCNG2 and ovarian cancer: For instance, a study by Bernaudo et al. found that CCNG2 can effectively suppress the epithelial-mesenchymal transition of ovarian cancer cells by inhibiting Wnt/β-catenin signal transduction (Bernaudo et al., 2016).